| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 7.86▼ | 8.07▼ | 8.07▼ | 7.85▼ | 7.62▼ |
| MA10 | 8.14▼ | 8.30▼ | 8.30▼ | 8.21▼ | 8.98▼ |
| MA20 | 8.41▼ | 8.43▼ | 8.43▼ | 7.85▼ | 15.08▼ |
| MA50 | 8.50▼ | 8.42▼ | 8.24▼ | 9.80▼ | 42.66▼ |
| MA100 | 7.66▼ | 7.44▲ | 7.77▼ | 18.83▼ | 229.17▼ |
| MA200 | 7.52▼ | 8.76▼ | 9.79▼ | 35.92▼ | 2,011.18▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.120▼ | -0.138▼ | -0.143▼ | 0.099▲ | 2.942▲ |
| RSI | 34.627▼ | 35.830▼ | 36.346▼ | 38.637▼ | 31.242▼ |
| STOCH | 16.672▼ | 18.408▼ | 18.408▼ | 25.577 | 21.332 |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -95.975▼ | -79.941▼ |
| CCI | -152.730▼ | -185.402▼ | -185.402▼ | -251.297▼ | -75.327 |
|
Monday, November 16, 2026 04:30 AM
Completed treatment of all 90 patients in Part A of the pivotal Phase 2/3 MIRACLE trial evaluating Annamycin in relapsed or refractory acute myeloid leukemia (AML) - Comprehensive Part A data readout ...
|
|
Thursday, November 12, 2026 05:37 AM
Patent strengthens intellectual property protection for preparation of preliposomal Annamycin lyophilizate HOUSTON, Nov. 12, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: MBRX) (“Moleculin” or the “Company”) ...
|
|
Friday, November 06, 2026 02:32 PM
As per the SEC Form 4 filing, Jonathan P. Foster, CFO of Moleculin Biotech, Inc. (NASDAQ:MBRX) MBRX (NASDAQ:MBRX) , reported two transactions dated November 4, 2026. The first transaction, coded M, ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 16/11/26 | 7.56 | 7.745 | 7.01 | 7.14 | 19,147 |
| 13/11/26 | 8.00 | 8.101 | 7.71 | 7.87 | 9,901 |
| 12/11/26 | 8.77 | 8.90 | 7.90 | 8.06 | 42,177 |
| 11/11/26 | 8.08 | 8.40 | 8.00 | 8.10 | 14,136 |
| 10/11/26 | 8.51 | 8.87 | 8.01 | 8.06 | 20,704 |
| 09/11/26 | 8.83 | 8.88 | 8.52 | 8.66 | 17,381 |
| 06/11/26 | 8.88 | 8.94 | 8.53 | 8.70 | 14,275 |
| 05/11/26 | 8.46 | 8.96 | 7.74 | 8.73 | 25,169 |
| 04/11/26 | 8.13 | 8.6508 | 8.13 | 8.46 | 13,782 |
| 03/11/26 | 8.27 | 8.4199 | 8.27 | 8.30 | 12,485 |
|
|
||||
|
|
||||
|
|